These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

503 related items for PubMed ID: 27916754

  • 1.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 2.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 3.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 4. Inflammatory myopathies and overlap syndromes: Update on histological and serological profile.
    Colafrancesco S, Priori R, Valesini G.
    Best Pract Res Clin Rheumatol; 2015 Dec; 29(6):810-25. PubMed ID: 27107515
    [Abstract] [Full Text] [Related]

  • 5. Immune-mediated necrotizing myopathy (IMNM): A myopathological challenge.
    Merlonghi G, Antonini G, Garibaldi M.
    Autoimmun Rev; 2022 Feb; 21(2):102993. PubMed ID: 34798316
    [Abstract] [Full Text] [Related]

  • 6. [Myositis-specific autoantibodies].
    Fujimoto M.
    Brain Nerve; 2013 Apr; 65(4):449-60. PubMed ID: 23568993
    [Abstract] [Full Text] [Related]

  • 7. Autoimmune myopathies: autoantibodies, phenotypes and pathogenesis.
    Mammen AL.
    Nat Rev Neurol; 2011 Jun 08; 7(6):343-54. PubMed ID: 21654717
    [Abstract] [Full Text] [Related]

  • 8. Peculiar clinicopathological features of immune-mediated necrotizing myopathies.
    Allenbach Y, Benveniste O.
    Curr Opin Rheumatol; 2018 Nov 08; 30(6):655-663. PubMed ID: 30239349
    [Abstract] [Full Text] [Related]

  • 9. Development of a New Classification System for Idiopathic Inflammatory Myopathies Based on Clinical Manifestations and Myositis-Specific Autoantibodies.
    Mariampillai K, Granger B, Amelin D, Guiguet M, Hachulla E, Maurier F, Meyer A, Tohmé A, Charuel JL, Musset L, Allenbach Y, Benveniste O.
    JAMA Neurol; 2018 Dec 01; 75(12):1528-1537. PubMed ID: 30208379
    [Abstract] [Full Text] [Related]

  • 10. [Usefulness of autoantibodies for the diagnosis of autoimmune myopathies].
    Allenbach Y, Benveniste O.
    Rev Neurol (Paris); 2013 Dec 01; 169(8-9):656-62. PubMed ID: 23642286
    [Abstract] [Full Text] [Related]

  • 11. Clinical features and prognosis in anti-SRP and anti-HMGCR necrotising myopathy.
    Watanabe Y, Uruha A, Suzuki S, Nakahara J, Hamanaka K, Takayama K, Suzuki N, Nishino I.
    J Neurol Neurosurg Psychiatry; 2016 Oct 01; 87(10):1038-44. PubMed ID: 27147697
    [Abstract] [Full Text] [Related]

  • 12. [Diagnosis of Idiopathic Inflammatory Myopathy: A Muscle Pathology Perspective].
    Inoue M, Nishino I.
    Brain Nerve; 2016 Dec 01; 68(12):1431-1441. PubMed ID: 27916753
    [Abstract] [Full Text] [Related]

  • 13. Immune-mediated necrotizing myopathy: A comprehensive review of the pathogenesis, clinical features, and treatments.
    Li C, Liu H, Yang L, Liu R, Yin G, Xie Q.
    J Autoimmun; 2024 Sep 01; 148():103286. PubMed ID: 39033686
    [Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18. Immune-mediated necrotizing myopathy is characterized by a specific Th1-M1 polarized immune profile.
    Preuße C, Goebel HH, Held J, Wengert O, Scheibe F, Irlbacher K, Koch A, Heppner FL, Stenzel W.
    Am J Pathol; 2012 Dec 01; 181(6):2161-71. PubMed ID: 23058368
    [Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 26.